0001968202-24-000072.txt : 20240226
0001968202-24-000072.hdr.sgml : 20240226
20240226160725
ACCESSION NUMBER: 0001968202-24-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SING GEORGE L
CENTRAL INDEX KEY: 0001225471
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 24678722
MAIL ADDRESS:
STREET 1: LANCET CAPITAL
STREET 2: 45 ROCKEFELLER PLAZA STE 2008
CITY: NEW YORK
STATE: NY
ZIP: 10111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-02-22
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001225471
SING GEORGE L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
0
Common Stock
2024-02-22
4
M
0
1000
413.33
A
27349
D
Common Stock
2024-02-22
4
S
0
1000
970.0
D
26349
D
Common Stock
2024-02-22
4
M
0
1000
413.33
A
27349
D
Common Stock
2024-02-22
4
S
0
1000
965.0
D
26349
D
Common Stock
2024-02-22
4
M
0
1000
413.33
A
27349
D
Common Stock
2024-02-22
4
S
0
1000
960.0
D
26349
D
Common Stock
2024-02-23
4
M
0
500
413.33
A
26849
D
Common Stock
2024-02-23
4
S
0
500
985.0
D
26349
D
Common Stock
750
I
by Spouse
Common Stock
400
I
by Spouse/Cust Son
Common Stock
1000
I
by Trust for Son
Non-Qualified Stock Option (right to buy)
413.33
2024-02-22
4
M
0
3000
0.0
D
2025-01-02
Common Stock
3000
6838
D
Non-Qualified Stock Option (right to buy)
413.33
2024-02-23
4
M
0
500
0.0
D
2025-01-02
Common Stock
500
6338
D
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**George L. Sing
2024-02-26